Back to Results
First PageMeta Content
Health / HIV vaccine / HIV / Nef / Simian immunodeficiency virus / AIDS / Acute HIV infection / Immune system / T helper cell / HIV/AIDS / Medicine / Biology


Control of Viremia and Prevention of AIDS following Immunotherapy of SIV-Infected Macaques with PeptidePulsed Blood Robert De Rose1, Caroline S. Fernandez1, Miranda Z. Smith1, C. Jane Batten1, Sheilajen Alcaˆntara1, Viv
Add to Reading List

Document Date: 2013-05-09 21:26:48

Open Document

File Size: 491,93 KB

Share Result on Facebook

City

Davis / Recombinant / Fitzroy / Parkville / Melbourne / Foster City / /

Company

Linde / Opal Therapeutics Pty Ltd / Mayne AE / OPALAll / Proc Natl Acad Sci U S A / National Serology Reference Laboratory / VL / Advanced Biosciences / OPAL-All / Arraes LC / OPAL-Gag / Cox / Subtype AE / Ryder / Creative Commons / BD Biosciences / Medicines Development Ltd / /

Country

United States / Australia / /

Currency

pence / /

/

Event

FDA Phase / Product Recall / M&A / Product Issues / /

Facility

University of New South Wales / National Cancer Institute / University of Melbourne / /

IndustryTerm

vaccination / venture capital / per-protocol / biotechnology / pre-written protocol / control / vaccine technology / vaccine / Prevention of AIDS / /

MedicalCondition

DF / chronic viral diseases / simian AIDS / HIV viremia / JE / HIV / animals controlling viremia / hepatitis C / melanoma / acute SIV infection / tissue culture infectious doses / Treated Acute HIV Infection / MS / cancers / Massive infection / Human Immunodeficiency Virus Infections / Opportunistic infections / disease / lethargy / primary SIV251 infection / Viremia / early infection / virus infection / AIDS / initial vaccinations infection / infection / SIVmac251 infection / SIV infection / acute infection / progressive HIV disease / human papilloma virus-simian/human immunodeficiency virus virus-likeparticle vaccines / dehydration / following SIV infection / /

MedicalTreatment

immunization / Adoptive transfer / antiretroviral treatment / anti-retroviral therapy / immunotherapies / antiretroviral therapy / immunizations / highly active antiretroviral therapy / vaccination / Immunotherapy / vaccinations / Drug therapies / drug therapy / /

Organization

National Cancer Institute / University of Melbourne / National Institute of Health / Therapeutic Goods Administration / Australian Centre for HIV / National Centre for HIV Epidemiology / Medical Research Council / Australian National Health and Medical Research Council / University of New South Wales / Sydney / Department of Microbiology and Immunology / /

Person

Simon V / Richard A. Koup / /

Position

Hartigan PM / original author / Editor / RD CF MS CB SA VP / Author / VP ER LL RM KW AH SK / Fisher / Representative / /

Product

Sigma / ART / SIV / /

ProgrammingLanguage

DC / /

ProvinceOrState

Saskatchewan / Maryland / Victoria / New South Wales / California / /

PublishedMedium

PLoS Pathogens / /

RadioStation

Caliendo AM / /

Region

South Wales / /

Technology

pre-written protocol / antibodies / biotechnology / PDF / /

URL

www.plospathogens.org / /

SocialTag